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Background
Although sexual transmission represents the main mode
of HIV dissemination worldwide, little is known about
the influence of semen on viral spread. We have shown
that seminal plasma (SP) inhibits both, the attachment of
HIV to dendritic cells (DC) and the ability of DC to trans-
mit the virus to T cells. Here, we characterized the inhibi-
tor present in SP and their functional properties.
Methods
Semen samples were collected from healthy donors. SP
proteins were analyzed by 2D electrophoresis. DC-SIGN
binding proteins were identified by western blot using
DC-SIGNfc chimera. Selected spots were cut and clusterin
was identified by MS analysis as the inhibitor present in
SP. SP clusterin was then purified by affinity chromatog-
raphy. In all the experiments, HIV was quantified by
measurement of p24 antigen by ELISA.
Results
We found that SP clusterin markedly inhibits the attach-
ment of HIV-1 BAL (5 ng p24 antigen) to DC in a dose-
dependent mode (1–40 μg/ml), being the percentage of
inhibition of 54 ± 11(n = 6, p < 0.05) when used at a con-
centration of 15 μg/ml. Similar levels of inhibition were
observed using blocking antibodies directed to DC-SIGN.
In transmission experiments DC were cultured with HIV-
1 BaL (5 ng p24Ag) in the presence of clusterin (20 μg/
ml), washed and cultured with activated peripheral blood
mononuclear cells (PBMCs). Clusterin markedly pre-
vented virus transmission to DC: % inhibition = 59 ± 17,
n = 5, p < 0.05). Experiments performed with THP-1-DC-
SIGN+ cells showed that clusterin, at a concentration of
15 ug/ml, almost completely inhibited both, the attach-
ment of HIV (% inhibition < 87%, n = 5) and the ability
of THP-1-DC-SIGN+ cells to transmit the virus to acti-
vated PBMCs (% inhibition < 82%, n = 4).
Conclusion
Our results identified clusterin, as a novel ligand of DC-
SIGN present in human semen able to inhibit the capture
and transmission of HIV by DC.
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